课题基金 / 基金详情

Study of effects of antiglaucoma eye drops on glaucomatous optic neuropathy and ocular serface.

Study of effects of antiglaucoma eye drops on glaucomatous optic neuropathy and ocular serface.
抗青光眼滴眼液对青光眼视神经病变及眼部神经病变的影响研究。
批准号:
16591738
负责人:
OHGURO Ikuyo
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

OHGURO Ikuyo的其他基金

相似基金

相关文献

中文摘要
翻译
目的:目的:研究抗青光眼滴眼液对N-甲基-D-天冬氨酸(NMDA)诱导的视网膜损伤及眼表的影响。用几种抗青光眼滴眼液、β-受体阻滞剂、α/β-受体阻滞剂、α_1受体阻滞剂、α_2受体激动剂和前列腺素衍生物局部给药于NMDA处理的大鼠眼和未处理的大鼠眼,观察视网膜厚度、逆行标记视网膜神经节细胞(RGC)数量、结果:玻璃体内注射NMDA可使视网膜层厚度明显减少,并诱导胶质细胞增生蛋白(GFAP)表达上调。局部给予β受体阻滞剂和前列腺素衍生物对视网膜厚度、RGCs数量或GFAP表达几乎没有显著影响。而α/β受体阻滞剂、α 1受体阻滞剂和α 2受体激动剂对视网膜厚度和RGCs数量有保护作用,并能显著抑制NMDA诱导的GFAP表达上调。在1101个与细胞调节机制相关的基因中,胰岛素样生长因子IGF-1和ErbB 3的两个基因的表达在α/β阻断剂、α_1阻断剂和α_2激动剂给药后发生改变。结论:抗青光眼滴眼液通过调节α肾上腺素能受体(α 1受体阻滞剂和α 2受体激动剂),对NMDA诱导的大鼠视网膜损伤具有保护作用。α/β受体阻滞剂、α_1受体阻滞剂和前列腺素衍生物可诱导ECM降解,影响滤过手术。
英文摘要
Purpose : To study the effects of antiglaucoma eye drops on N-methyl-D-aspartate (NMDA)-induced retinal damage and ocular surfaceMethods : Several antiglaucoma eye drops, β-blockers, α/β-blockers, an α_1-blocker, and α_2-agonist, and a prostaglandin derivative, were topically administrated to NMDA-treated rat eyes or non-treated rat eye, and the retinal thickness, the number of retrograde-labeled retinal ganglion cells (RGCs), the results of a cDNA microarray analysis, and the levels of matrix metalloprotease (MMP) and tissue inhibitor of matrix protease (TIMP) which regulate the metabolism of the extracellular matrix (ECM) were studied.Results : Intravitreal administration of NMDA caused a significant decrease in the thickness of the retinal layers and induced upregulation of glial fibrillary protein (GFAP). Topical administration of β-blockers and a prostaglandin derivative showed almost no significant effects on retinal thickness, the number of RGCs, or expression of GFAP. In contrast, the α/β-blockers, the α_1-blocker, and the α_2-agonist showed preservation effects on retinal thickness and the the number of RGCs, and marked suppression of NMDA-induced upregulation of GFAP. Among 1101 genes related to cellular regulatory mechanisms, the expression of two genes, both for insulin-like growth factors, IGF-1 and ErbB3,was altered upon administration of the α/β-blockers, the α_1-blocker, and the α_2-agonist. In addition, topical administration of the α/β-blockers, the α_1-blocker, and the prostaglandin derivative induced upregulation of MMP and downregulation of TIMP of conjunctiva.Conclusion : Our present study suggests that modulations of the α-adrenergic receptor, α_1-blocking, and α_2-stimulation, by antiglaucoma eye drops may cause beneficial effects on NMDA-induced retinal damage in the rat. Our results also suggests that the α/β-blockers, the α_1-blocker, and the prostaglandin derivative induce degradation of ECM, affcting filter surgery.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
緑内障セミナー 48.緑内障と自己免疫疾患
青光眼研讨会48.青光眼与自身免疫性疾病
DOI: --
发表时间: 2004
期刊: あたらしい眼科 21
影响因子: --
作者: [大黒幾代, ほか]
通讯作者: ほか
緑内障性視神経障害における眼圧非依存因子の検討-血小板凝集能との係わり-
青光眼性视神经病变眼压非依赖性因素的检查-与血小板聚集能力的关系-
DOI: --
发表时间: 2005
期刊: あたらしい眼科 22
影响因子: --
作者: [大黒幾代, 大黒 浩, 他]
通讯作者: 他
Effects of matrix metalloproteinase-3 gene transfer by electroporation in glaucoma filter surgery.
电穿孔基质金属蛋白酶 3 基因转移在青光眼滤过性手术中的效果。
DOI: --
发表时间: 2004
期刊: Exp Eye Res 79
影响因子: --
作者: [Mamiya K, Ohguro I, et al.]
通讯作者: et al.
正常眼圧にもかかわらず、緑内障様視野異常や角膜径増大を呈した発達緑内障疑いの2例
疑似发育性青光眼两例,尽管眼压正常,但出现青光眼样视野异常和角膜直径增大
DOI: --
发表时间: 2005
期刊: 眼科 47
影响因子: --
作者: [大黒幾代, 大黒 浩, 他]
通讯作者: 他
共 14 条
    Study of autoimmune mechanisms in molecular pathology of glaucomatous optic neuropathy.
    • 批准号:
      14571653
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      2002
    • 负责人:
      OHGURO Ikuyo
    • 依托单位:
    国内基金
    海外基金
    酸敏感离子通道功能与调控机理研究
    • 批准号:
      30830035
    • 项目类别:
      重点项目
    • 资助金额:
      190.0万元
    • 批准年份:
      2008
    • 负责人:
      徐天乐
    • 依托单位: